Filing metadata

Accession number
0000950170-25-074667
Form type
Form 4
Filer
Ultragenyx Pharmaceutical Inc.
CIK
CIK 1515673
Filed
May 19, 2025
Reporting period
May 15, 2025
Description
Insider transaction

Explore SEC Filings Hub